GEN | News Highlights: FDA Clears Roche/Chugai’s mAb for Rheumatoid Arthritis

Links shared publicly online about this topic.

  • 1,454
    total visits

GEN | News Highlights: FDA Clears Roche/Chugai’s mAb for Rheumatoid Arthritis

genengnews.com —

Actemra was first launched in Japan for Castleman disease. Japanese approval for RA and juvenile idiopathic arthritis was granted later.

View full resource at genengnews.com

Tags: Arthritis, Rheumatoid Arthritis, Rheumatoid Arthritis Medication, Disease and Condition, FDA, Actemra, News, disease

  • Share

Most Recently Shared on January 15, 2010 at 4:27 pm By:

pshuster Pete Shuster

FDA Clears Roche/Chugai’s mAb for Rheumatoid Arthritis http://is.gd/64Gaf

2 years ago...

Reply

Retweet

Favorite

Advertisement